Found 249 matching trials
To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI Development NA The role of Albumin in prevention and Treatment of Acute Kidney Injury (AKI...
Show More Location
Institute of Liver & Biliary Sciences
Learn More & Join Trial
Comparison of Crystalloid and Colloid I.V Fluid Therapy in Prevention of Paracentesis Induced Circulatory Dysfunction (PICD) and Renal Dysfunction in Patients With Decompensated Liver Cirrhosis in Egypt: a Randomized Piolet Study N/A 2.2 Aim(s) of the Research (50 words max):
To Compare between crystalloid ...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy PHASE1 The study was a 48-week multicenter, randomized, double-blind, placebo-cont...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD PHASE2 The purpose of the study is to evaluate the safety and efficacy of GLASSIA ...
Show More Location
Georgia Cancer Center
Learn More & Join Trial
Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis PHASE1 Autoimmune hepatitis (AIH) is characterized by chronic inflammation of the ...
Show More Location
Beijing 302 Hospital
Learn More & Join Trial
Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure. NA This was a non-blinded, prospective clinical study. From June 2020 to Octob...
Show More Location
Xiangya Hospital of Central South University
Learn More & Join Trial
Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study) PHASE2 Coronary artery disease (CAD) is a common disorder that can lead to heart f...
Show More Location
University of Florida-Department of Medicine
Learn More & Join Trial
Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment PHASE1 Lurbinectedin is mainly eliminated by the liver. Thus, Hepatic Impairment (...
Show More Location
Hospital Universitario Virgen de la Victoria
Learn More & Join Trial
Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer PHASE2 The primary scientific question of interest of this study is whether the co...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT PHASE4 The aim of this study is to evaluate difference in the rate of recovery of ...
Show More Location
Seoul National University Hospital
Learn More & Join Trial